Login / Signup

Sulfonylurea for improving neurological features in neonatal diabetes: A systematic review and meta-analyses.

Caroline de Gouveia Buff PassoneElisa GianiLaurence Vaivre-DouretDulanjalee KariyawasamMarianne BerdugoLaure GarcinJacques BeltrandWanderley Marques BernardoMichel Polak
Published in: Pediatric diabetes (2022)
Glibenclamide significantly improved neurological abnormalities in patients with neonatal-onset diabetes due to KCNJ11 or ABCC8 mutations. Hypotonia was the symptom that responded best. Earlier treatment initiation was associated with greater benefits.
Keyphrases
  • meta analyses
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • systematic review
  • randomized controlled trial
  • cerebral ischemia
  • adipose tissue
  • brain injury